New hope for tough cancers: experimental drug IMGS-001 enters human trials
Disease control
Recruiting now
This early-stage trial tests an experimental drug called IMGS-001 in people with advanced solid tumors that have come back or stopped responding to standard treatments. The study has two parts: first, finding a safe dose, then testing that dose in specific cancer types like ovari…
Phase: PHASE1 • Sponsor: ImmunoGenesis • Aim: Disease control
Last updated May 22, 2026 13:54 UTC